Filling the need for trusted information on national health issues…

Access to Health Services

  • Your Selections:

Refine Results

date

Tags

Important To Include Men In HIV Prevention, Treatment Programs

While a focus on HIV prevention and treatment among women and children has reduced infection rates among these populations, “men have received considerably less attention in the epidemic and receive less targeted HIV prevention and treatment programs,” Edward Mills of the University of Ottawa and colleagues write in a PLoS Medicine essay, adding “Targeting men in prevention and treatment … may have a large impact on mortality, new infections, and the economic impact of HIV/AIDS in Africa.” They note that in Africa, fewer men than women access antiretroviral therapy (ART), and men “typically have higher mortality,” seek care later in the disease, and “are more likely to be lost to follow-up.”

USAID-Supported Programs Fighting TB, HIV In Brazil

In this post in USAID’s “IMPACTblog,” Ed Scholl, AIDSTAR-One project director, writes about HIV and tuberculosis (TB) care in Brazil, where “USAID has partnered with the Brazilian Ministry of Health to improve early TB detection, increase HIV counseling and testing, and provide medical treatment for both infections.” He continues, “AIDSTAR-One, a USAID-funded project, is also conducting outreach in Brazilian prisons, which are often at high risk of TB and HIV epidemics.” He concludes, “Through partnerships like USAID and AIDSTAR-One, we can effectively fight TB and HIV across Brazil and Latin America, to improve the health of countless people and ultimately save lives” (2/7).

Eye Clinics In India Use Tiered Pricing To Provide Affordable Service To Poorest Patients

“An expanding network of eye clinics has found an innovative way of providing quality, affordable treatment to millions of blind and visually impaired poor people in India,” the Guardian’s “Poverty Matters” blog reports. The LV Prasad Eye Institute (LVPEI), a not-for-profit organization that runs a chain of 82 eye care centers and a research institute in India, uses tiered pricing to charge wealthier patients for treatment, allowing the group to provide free treatment to poorer patients.

U.N. Says Asia Pacific Region Making Strides Against HIV/AIDS, Must Address Social And Legal Barriers To Treatment, Prevention

The U.N. Economic and Social Commission for the Asia Pacific (ESCAP) on Monday in Bangkok “opened a three-day meeting lauding impressive gains in recent years in the fight against HIV/AIDS,” but the body cautioned “there are still legal and social barriers that significantly set back eradication efforts,” VOA News reports. U.N. ESCAP Executive Secretary Noeleen Heyzer “note[d] the gains are uneven and there are still gaps in the goal of universal access to HIV treatment,” the news service writes.

Action Needed To Reach Ambitious Targets Set Forth In President’s World AIDS Day Speech

President Barack Obama’s December 1 World AIDS Day speech “could be pivotal, but only if it is followed by changes in how we tackle global AIDS,” Chris Collins, vice president and director of public policy at amfAR, The Foundation for AIDS Research, writes in this Huffington Post “Global Motherhood” opinion piece. “Obama signaled a renewed U.S. commitment to funding for global AIDS programs at a time when resources at home are constrained and other countries are backing away from the fight,” he writes, adding, “Now it’s time to plot a course for implementing the president’s vision.”

Guardian Blog Interviews Researcher Regarding Artemisinin Synthesis Discovery

In this post in the Guardian’s “The Observer,” Mark Honigsbaum, a research associate at the University of Zurich’s Institute for Medical History, interviews Peter Seeberger, the director of the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, about a recent announcement that Seeberger and colleague François Lévesque “have discovered a simple and cost-effective way of synthesizing artemisinin from the waste products of the” sweet wormwood plant from which it is extracted. Honigsbaum notes that “extracting artemisinin is expensive and because it takes time to cultivate the plant there are often bottlenecks in supply,” and writes, “Their discovery has the potential to make the drug more affordable for the 225 million people affected by malaria every year” (2/4).

Economic Transformation In Latin America An Opportunity To Improve NTD Strategies, DNDi Regional Director Says

“The rise of emerging economies in Latin America is an opportunity to improve strategies for fighting neglected illnesses and increase the region’s contribution to the global struggle against them, says” Eric Stobbaerts, the Latin America director of the independent Drugs for Neglected Diseases initiative (DNDi), Inter Press Service reports. “Our region is going through a major transformation in economic and social terms,” Stobbaerts told IPS after a meeting on “Uniting to Combat Neglected Tropical Diseases” (NTDs) held in London on January 30, “mentioning the progress that has been made in Argentina, Brazil, Colombia, Chile and Mexico,” IPS writes.

Kenyan AIDS Official Says Country Has Sufficient Funding To Support Programs Through 2016

Kenya has sufficient funds to support HIV/AIDS treatment programs through 2016, the head of the National AIDS Control Council (NACC) said in a statement on Wednesday after activists protested on Monday in support of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Star reports. The Global Fund had to cancel Round 11 grants because “the cash at hand was not in the bank by the time we wanted to disburse,” according to the Fund’s Deputy Executive Director Debrework Zewdie, a move that sparked fears there would not be sufficient funding to pay for existing treatment programs, the Star notes (Muchangi, 2/2). In his statement, NACC head Alloys Orago said, “Though the available fund cushions beneficiaries from immediate effects of donor withdrawal up to 2016, such a move calls for home grown and innovative ways of locally financing the disease,” according to the Daily Nation (2/2).

Republican Win In 2012 Election Could Spell End Of International Family Planning Programs

“If a Republican becomes president, … say goodbye to international programs providing birth control to women in desperately poor countries such as Liberia,” senior contributing writer Michelle Goldberg writes in this Daily Beast opinion piece. Goldberg notes that birth control has become a “significant issue in the U.S. presidential campaign,” writing, “All of the Republican candidates have slammed the administration’s refusal to give religious institutions a broad exemption from the mandate that insurance cover family planning.”

DRC Facing Decline In Donor Funding, HIV Treatment Shortage

“The lives of thousands of HIV-positive people in the Democratic Republic of Congo (DRC) are at risk as the country faces declining donor funding and a severe shortage of HIV treatment, according to Medecins Sans Frontieres (MSF),” PlusNews reports. “‘The problem is quite old in the DRC; the country has always been minimized by donors who have not seen it as a priority, mainly because HIV prevalence is relatively low at between three and four percent,’ Thierry Dethier, advocacy manager for MSF Belgium in the DRC, told IRIN/PlusNews,” and he added, “But look at the indicators: more than one million people are living with HIV, 350,000 of whom qualify for [antiretrovirals (ARVs)] but only 44,000 — or 15 percent — are on ARVs,” the news service writes.

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.